临床虚弱度尺度对于预测因冠状病毒疾病而入院的患者返回家园是有用的
Koki Kawamura1, Aiko Osawa2, Masanori Tanimoto2
1National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu, 474-8511, Aichi, Japan. kawamura@ncgg.go.jp.
BMC geriatrics
|July 13, 2023
概括
临床脆弱度量 (CFS) 有效预测COVID-19患者的家庭出院情况. 一个CFS得分为6或更高表明出院困难,有助于医院资源管理.
科学领域:
- 老年病的医生 老年病的医生
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19的流行,特别是Omicron变种,导致了长时间的住院治疗.
- 在COVID-19治疗单位的患者往往会出现废弃综合征,损害日常生活活动,并使出院复杂化.
- 预测出院安排对于管理医院资源和患者护理至关重要.
研究的目的:
- 为了研究脆弱性和患者从COVID-19治疗单位出院到家的能力之间的关系.
- 确定脆弱性作为老年COVID-19患者出院结果的潜在预测因素.
主要方法:
- 在2022年入住COVID-19治疗单位的138名患者的回顾性分析.
- 使用临床脆弱度量表 (CFS) 评估脆弱性.
- 用ROC曲线和后勤回归分析比较出院的患者与出院困难的患者.
主要成果:
- 诊断出临床虚弱度表 (CFS) 截止值为6或以上,预测出院困难的灵敏度为70.7%,特异性为84.1%.
- 后勤回归显示,CFS与在家出院的可能性之间存在显著的相关性 (OR=13.44).
- 75名患者被送回家,而63人面临出院挑战.
结论:
- 在COVID-19治疗单位使用CFS进行脆弱性评估可以准确预测家庭出院潜力.
- 慢性肺炎作为一种有效的查工具,用于识别需要在急性COVID-19治疗后继续住院的患者.
- 早期识别脆弱性可以优化COVID-19患者的出院计划和资源分配.
相关概念视频
01:21Acute Respiratory Failure-II
278
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
278
01:29Documentation in Long-Term and Home Healthcare Setting
931
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
931
01:30Pneumonia III: Complications and Assessment
274
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
274
01:30Acute Respiratory Failure-III
227
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
227
01:29Acute Respiratory Failure-V
166
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
166
01:21Acute Respiratory Failure-I
251
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
251